Raras
Buscar doenças, sintomas, genes...
Síndrome de rubéola congênita
ORPHA:290CID-10 · P35.0CID-11 · KA62.8DOENÇA RARA

É uma condição infecciosa que afeta o bebê ainda na barriga da mãe (feto). Ela ocorre quando a mãe é infectada pelo vírus da rubéola e o transmite para o feto. Essa condição pode se manifestar no bebê após o nascimento e causar surdez, catarata e várias outras sequelas permanentes, como problemas no coração e no cérebro.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

É uma condição infecciosa que afeta o bebê ainda na barriga da mãe (feto). Ela ocorre quando a mãe é infectada pelo vírus da rubéola e o transmite para o feto. Essa condição pode se manifestar no bebê após o nascimento e causar surdez, catarata e várias outras sequelas permanentes, como problemas no coração e no cérebro.

Publicações científicas
1.243 artigos
Último publicado: 2026 Mar 5

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Antenatal
+ neonatal
🏥
SUS: Cobertura mínimaScore: 20%
Centros em: RS, PR, SC, PA, PE +10CID-10: P35.0
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
8 sintomas
🧠
Neurológico
5 sintomas
❤️
Coração
3 sintomas
📏
Crescimento
2 sintomas
🫃
Digestivo
2 sintomas
🩸
Sangue
2 sintomas

+ 6 sintomas em outras categorias

Características mais comuns

90%prev.
Deficiência auditiva neurossensorial
Muito frequente (99-80%)
90%prev.
Anormalidade da fala ou vocalização
Muito frequente (99-80%)
90%prev.
Retardo do crescimento intrauterino
Muito frequente (99-80%)
90%prev.
Catarata
Muito frequente (99-80%)
55%prev.
Anormalidade das fontanelas ou suturas cranianas
Frequente (79-30%)
55%prev.
Hipotonia
Frequente (79-30%)
31sintomas
Muito frequente (4)
Frequente (22)
Ocasional (5)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 31 características clínicas mais associadas, ordenadas por frequência.

Deficiência auditiva neurossensorialSensorineural hearing impairment
Muito frequente (99-80%)90%
Anormalidade da fala ou vocalizaçãoAbnormality of speech or vocalization
Muito frequente (99-80%)90%
Retardo do crescimento intrauterinoIntrauterine growth retardation
Muito frequente (99-80%)90%
CatarataCataract
Muito frequente (99-80%)90%
Anormalidade das fontanelas ou suturas cranianasAbnormality of the fontanelles or cranial sutures
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico1.243PubMed
Últimos 10 anos200publicações
Pico202241 papers
Linha do tempo
2026Hoje · 2026🧪 2012Primeiro ensaio clínico📈 2022Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
Aprovado1
3Fase 31
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 2 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de rubéola congênita

Centros de Referência SUS

24 centros habilitados pelo SUS para Síndrome de rubéola congênita

Centros para Síndrome de rubéola congênita

Detalhes dos centros

Hospital Universitário Prof. Edgard Santos (HUPES)

R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFG

Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Universitário da UFJF

R. Catulo Breviglieri, Bairro - s/n - Santa Catarina, Juiz de Fora - MG, 36036-110 · CNES 2297442

Atenção Especializada

Rota
Anomalias Congênitas

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Julio Müller (HUJM)

R. Luis Philippe Pereira Leite, s/n - Alvorada, Cuiabá - MT, 78048-902 · CNES 2726092

Atenção Especializada

Rota
Anomalias Congênitas

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Lauro Wanderley (HULW)

R. Tabeliao Estanislau Eloy, 585 - Castelo Branco, João Pessoa - PB, 58050-585 · CNES 0002470

Atenção Especializada

Rota
Anomalias Congênitas

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital Universitário Regional de Maringá (HUM)

Av. Mandacaru, 1590 - Parque das Laranjeiras, Maringá - PR, 87083-240 · CNES 2216108

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Pedro Ernesto (HUPE-UERJ)

Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital São Lucas da PUCRS

Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário da UFSC (HU-UFSC)

R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Base de São José do Rio Preto

Av. Brg. Faria Lima, 5544 - Vila Sao Jose, São José do Rio Preto - SP, 15090-000 · CNES 2079798

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

UNIFESP / Hospital São Paulo

R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

2 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
424 papers (10 anos)
#1

Rubella outbreak investigation in Adigrat town of Eastern Tigray, Northern Ethiopia, 2024: case-control study design.

BMC public health2026 Jan 20

Rubella virus infection is a clinically mild illness, but it can have serious effects on pregnant women, such as miscarriage, stillbirth, or congenital rubella syndrome. However, rubella is neither a notifiable disease nor part of an immunization program in Ethiopia. A suspected case of rubella has been reported in Adigrat since November 26, 2023. The study aimed to investigate and control the suspected rubella outbreak. Following the descriptive study, a case-control study was conducted in Adigrat town from December 23, 2023, to March 30, 2024. Cases were people who presented with fever and maculopapular or laboratory-confirmed cases or epidemiologically linked with the confirmed person, and controls were neighbours to a case with no signs and symptoms of rubella. Cases were selected using simple random sampling, and controls were the two closest neighbours per case. Data was collected using a semi-structured questionnaire and analysed with SPSS version 27. Logistic regression was used to determine the association of illness with risk factors, and the results were tested using OR, a 95% confidence interval. A total of 350 cases of rubella were identified with an attack rate of 3.16/1000. The attack rate was high in children aged five to nine years (11/1000) and in kebelle 04 (8/1000). Five out of seven samples were tested positive for rubella-specific IgM antibodies. Having contact in a school setting (AOR = 7.063: 95% CI = 3.269-15.256), having household contact (AOR = 6.551:95%CI = 2.534-16.941) and ≥ 5 family size (AOR = 2.312:95%CI = 1.090-4.907) were significantly associated with rubella. The overall attack rate of the rubella outbreak was high, with a predominance of children under fifteen. Large family size, and having contact with infected individuals, were contributing factors for contracting rubella. Rubella vaccine should be considered to prevent similar outbreaks.

#2

Clinical progress note: Rubella.

Journal of hospital medicine2026 Feb

Rates of rubella infection and congenital rubella syndrome decreased significantly since the introduction of the rubella vaccine in 1969. Endemic rubella was declared eliminated in the United States in 2004, and since 2012, all rubella cases in the United States have been associated with infections acquired abroad. With vaccine rates falling worldwide and outbreaks of vaccine preventable diseases increasing, it is important for clinicians to be prepared to recognize and manage diseases they may have never seen before, including rubella. This article reviews the clinical manifestations, complications, diagnosis, management, and prevention of acute rubella infection and congenital rubella syndrome.

#3

Notes from the Field: Congenital Rubella Syndrome - Florida, 2025.

MMWR. Morbidity and mortality weekly report2026 Mar 05
#4

Modeling Reemergence of Vaccine-Eliminated Infectious Diseases Under Declining Vaccination in the US.

JAMA2025 Jun 24

Widespread childhood vaccination has eliminated many infectious diseases in the US. However, vaccination rates are declining, and there are ongoing policy debates to reduce the childhood vaccine schedule, which may risk reemergence of previously eliminated infectious diseases. To estimate the number of cases and complications in the US under scenarios of declining childhood vaccination for measles, rubella, poliomyelitis, and diphtheria. A simulation model was used to assess the importation and dynamic spread of vaccine-preventable infectious diseases across 50 US states and the District of Columbia. The model was parameterized with data on area-specific estimates for demography, population immunity, and infectious disease importation risk. The model evaluated scenarios with different vaccination rates over a 25-year period. Inputs for current childhood vaccination rates were based on 2004-2023 data. The primary outcomes were estimated cases of measles, rubella, poliomyelitis, and diphtheria in the US. The secondary outcomes were estimated rates of infection-related complications (postmeasles neurological sequelae, congenital rubella syndrome, paralytic poliomyelitis, hospitalization, and death) and the probability and timing for an infection to reestablish endemicity. At current state-level vaccination rates, the simulation model predicts measles may reestablish endemicity (83% of simulations; mean time of 20.9 years) with an estimated 851 300 cases (95% uncertainty interval [UI], 381 300 to 1.3 million cases) over 25 years. Under a scenario with a 10% decline in measles-mumps-rubella (MMR) vaccination, the model estimates 11.1 million (95% UI, 10.1-12.1 million) cases of measles over 25 years, whereas the model estimates only 5800 cases (95% UI, 3100-19 400 cases) with a 5% increase in MMR vaccination. Other vaccine-preventable diseases are unlikely to reestablish endemicity under current levels of vaccination. If routine childhood vaccination declined by 50%, the model predicts 51.2 million (95% UI, 49.7-52.5 million) cases of measles over a 25-year period, 9.9 million (95% UI, 6.4-13.0 million) cases of rubella, 4.3 million cases (95% UI, 4 cases to 21.5 million cases) of poliomyelitis, and 197 cases (95% UI, 1-1000 cases) of diphtheria. Under this scenario, the model predicts 51 200 cases (95% UI, 49 600-52 600 cases) with postmeasles neurological sequelae, 10 700 cases (95% UI, 6700-14 600 cases) of congenital rubella syndrome, 5400 cases (95% UI, 0-26 300 cases) of paralytic poliomyelitis, 10.3 million hospitalizations (95% UI, 9.9-10.5 million hospitalizations), and 159 200 deaths (95% UI, 151 200-164 700 deaths). In this scenario, measles became endemic at 4.9 years (95% UI, 4.3-5.6 years) and rubella became endemic at 18.1 years (95% UI, 17.0-19.6 years), whereas poliovirus returned to endemic levels in about half of simulations (56%) at an estimated 19.6 years (95% UI, 14.0-24.7 years). There was large variation across the US population. Based on estimates from this modeling study, declining childhood vaccination rates will increase the frequency and size of outbreaks of previously eliminated vaccine-preventable infections, eventually leading to their return to endemic levels. The timing and critical threshold for returning to endemicity will differ substantially by disease, with measles likely to be the first to return to endemic levels and may occur even under current vaccination levels without improved vaccine coverage and public health response. These findings support the need to continue routine childhood vaccination at high coverage to prevent resurgence of vaccine-preventable infectious diseases in the US.

#5

A population-representative serosurvey estimating vaccine-induced immunity against measles, rubella, hepatitis B and severe acute respiratory syndrome coronavirus 2 in Timor-Leste.

The Lancet regional health. Southeast Asia2025 Mar

Serosurveillance can be used to assess population immunity to vaccine-preventable diseases (VPDs). This study aimed to determine seroprevalence of four VPDs across Timor-Leste and identify immunity gaps. A population-representative three-stage cluster random sample of census-enumerated households were visited between October 2021 and February 2023. Occupants aged above one year were tested for measles immunoglobulin G (IgG), rubella IgG, hepatitis B surface antibody (HBsAb), hepatitis B core antibody (HBcAb) and severe acute respiratory syndrome 2 (SARS-CoV-2) IgG, using serological assays with a priori determined cut-offs. Sample- and response-weighted mixed effects logistic regression models were used to estimate seroprevalence in relevant age-strata. Of 2613 eligible households, 1908 (73.0%) participated. Of 8427 occupants, 4750 (56.4%) participated. Measles IgG seroprevalence was low among children, particularly those aged 10-14 (33.2%, 95% confidence interval (CI) 27.8-38.6%). Rubella IgG seroprevalence was high in all ages (93.2%, 95% CI 92.2-94.2%). SARS-CoV-2 IgG seroprevalence was high, including in young children not eligible for vaccination (74.0%, 95% CI 70.4-77.6%). HBsAb seroprevalence was lowest among adolescents aged 15-19 (12.1%, 95% CI 6.8-17.5%) but higher among younger children, who also had low HBcAb seroprevalence. The pattern of measles immunity is consistent with low virus transmission and suboptimal childhood vaccine uptake. These data have informed supplementary immunisation activities. High rubella IgG seroprevalence suggests recent or ongoing virus transmission and a need for congenital rubella syndrome surveillance. Hepatitis B data provide evidence of recent improvements in vaccine-induced immunity and protection. This study demonstrates how serosurveillance can directly influence national vaccine strategies. This study was funded by the Department for Foreign Affairs and Trade, Australian Government (Complex Grant Agreement Number 75889).

Publicações recentes

Ver todas no PubMed

📚 EuropePMC535 artigos no totalmostrando 197

2026

Notes from the Field: Congenital Rubella Syndrome - Florida, 2025.

MMWR. Morbidity and mortality weekly report
2026

Rubella outbreak investigation in Adigrat town of Eastern Tigray, Northern Ethiopia, 2024: case-control study design.

BMC public health
2025

Perception of Rubella and readiness to accept the vaccine among medical students in Enugu and Ebonyi States, Nigeria.

BMC infectious diseases
2025

Identifying HPV vaccination research priorities for the US.

Human vaccines &amp; immunotherapeutics
2025

Rubella immunization policy in Japan: Immunity gaps arising from program differences and inconsistent cutoff standards.

Human vaccines &amp; immunotherapeutics
2025

Ocular manifestations of vaccine-preventable diseases: A comprehensive review.

Vaccine
2025

Serologic screening for anti-rubella immunoglobulin G antibodies in Romanian pregnant women: an unexpected rate of seronegativity.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2025

Rubella Seropositivity and Associated Factors Among Young Female Adults in Bangladesh: A Cross-Sectional Study.

International journal of general medicine
2025

Gene Expression Factors Associated with Rubella-Specific Humoral Immunity After a Third MMR Vaccine Dose.

Viruses
2026

Clinical progress note: Rubella.

Journal of hospital medicine
2025

Repeated Detection of Rubella Virus IgM Antibodies in Two Pregnancies Without Evidence of Fetal Infection: A Case Report and Challenges in Serological Interpretation.

Cureus
2025

Perinatal outcome of pregnant mothers with active rubella infection in a tertiary hospital in Nigeria.

Ghana medical journal
2025

Seroprevalence of Immunoglobulin G against measles and rubella over a 12-year period (2009-2021) in Kilifi, Kenya and the impact of the Measles-Rubella (MR) vaccine campaign of 2016.

Vaccine
2025

Long-term trends in rubella incidence across various regions and age groups in China, 2004-2021.

Frontiers in public health
2025

Results of Cochlear Implantation in Patients with Congenital Rubell-Retrospective Study.

Journal of clinical medicine
2025

Congenital Rubella Syndrome in the Post-Elimination Era: Why Vigilance Remains Essential.

Journal of clinical medicine
2025

Maternal exposure to rubella infection elevates risk of congenital rubella syndrome (CRS).

International review of neurobiology
2025

Estimated Current and Future Congenital Rubella Syndrome Incidence with and Without Rubella Vaccine Introduction - 19 Countries, 2019-2055.

MMWR. Morbidity and mortality weekly report
2025

A Case of Congenital Rubella Syndrome in the Netherlands: A Brief Report on Rubella Virus Surveillance.

The Pediatric infectious disease journal
2025

Diagnostic Challenges in Detecting Rubella Viral RNA in Cases of Congenital Rubella Syndrome Using RT-PCR in the Era of Elimination.

The Pediatric infectious disease journal
2025

Modeling Reemergence of Vaccine-Eliminated Infectious Diseases Under Declining Vaccination in the US.

JAMA
2025

Quantitative detection of rubella virus IgM antibodies using inductively coupled plasma mass spectrometry with elemental labeling: a new clinical application of mass spectrometry.

Analytical and bioanalytical chemistry
2025

Rubella seroprevalence among women of childbearing age in Tunis, Tunisia.

BMC infectious diseases
2025

[Lessons learned in the implementation of measles and rubella vaccination campaigns in the AmericasLições aprendidas com a implementação de campanhas de vacinação contra sarampo e rubéola na Região das Américas].

Revista panamericana de salud publica = Pan American journal of public health
2025

A population-representative serosurvey estimating vaccine-induced immunity against measles, rubella, hepatitis B and severe acute respiratory syndrome coronavirus 2 in Timor-Leste.

The Lancet regional health. Southeast Asia
2025

A journey worth taking: global eradication of measles, rubella and congenital rubella syndrome.

Expert review of vaccines
2025

Oxidative Stress Enhances Rubella Virus Infection in Immortalized Human First-Trimester Trophoblasts.

International journal of molecular sciences
2025

Corrigendum to "Sustainability of measles, rubella, and congenital rubella syndrome (CRS) elimination in the United States, January 2022 - June 2024" [Vaccine 46C (2025) 126681].

Vaccine
2024

Assessment of Simplified Surveillance for Congenital Rubella Syndrome in Sudan, 2014-2017.

Vaccines
2025

Continued elimination of measles, rubella and congenital rubella syndrome in the United States, January 2022-June 2024.

Vaccine
2024

Seroprevalence of measles antibody among immigrants in Gwangju, South Korea.

Frontiers in public health
2025

Sustainability of measles, rubella, and congenital rubella syndrome (CRS) elimination in the United States, January 2022 - June 2024.

Vaccine
2024

Impact of Immunization Strategies on Rubella Incidence During Progress Toward Rubella Control and Elimination - China, 2004-2023.

China CDC weekly
2024

[Successes and challenges in achieving and sustaining the elimination of measles, rubella, and congenital rubella syndrome in the Americas, 2013-2023Conquistas e desafios para alcançar e manter a eliminação do sarampo, da rubéola e da síndrome da rubéola congênita na Região das Américas, 2013-2023].

Revista panamericana de salud publica = Pan American journal of public health
2024

Sustaining measles and rubella elimination through the Regional Monitoring and Re-Verification Commission in the Americas.

Revista panamericana de salud publica = Pan American journal of public health
2024

Global challenges and solutions to achieving and sustaining measles and rubella elimination.

Revista panamericana de salud publica = Pan American journal of public health
2024

[A comprehensive approach to achieving reverification of measles elimination in Venezuela, 2019-2023Abordagem integral para a reverificação da eliminação do sarampo na Venezuela, 2019-2023].

Revista panamericana de salud publica = Pan American journal of public health
2024

Lessons for sustaining the elimination of measles, rubella, and congenital rubella syndrome in the Caribbean.

Revista panamericana de salud publica = Pan American journal of public health
2024

[Good practices in epidemiological surveillance for the sustainability of measles, rubella, and congenital rubella syndrome elimination in El Salvador, 2019-2023Boas práticas de vigilância epidemiológica para a sustentabilidade da eliminação do sarampo, da rubéola e da síndrome da rubéola congênita em El Salvador, 2019-2023].

Revista panamericana de salud publica = Pan American journal of public health
2024

Molecular epidemiology of rubella during the pre- and post-elimination eras in the Americas.

Revista panamericana de salud publica = Pan American journal of public health
2024

The Health and Economic Benefits of United States Investments in Measles and Rubella Control and Elimination.

Vaccines
2024

Rubella epidemiology in Lesotho after vaccine introduction: a five-year review, 2018-2022.

BMC public health
2024

Rubella seroprevalence among unvaccinated school-aged children in Jos, North Central, Nigeria.

The Pan African medical journal
2024

Care of children with congenital rubella syndrome (CRS) in Indonesia.

Journal of infection in developing countries
2024

Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) ad hoc meeting, 28 June - 1 July 2024.

Vaccine
2024

Congenital Rubella Syndrome: A Case Report from Somalia.

International medical case reports journal
2024

Congenital rubella syndrome, a case series.

Canada communicable disease report = Releve des maladies transmissibles au Canada
2025

How to Prevent Rubella Epidemics and Congenital Rubella Syndrome: Lessons From 42 Years of Longitudinal Epidemiology in Osaka Prefecture, Japan (1982-2023).

The Journal of infectious diseases
2024

Measles and Rubella Elimination in the Western Pacific Region in 2013-2022: Lessons Learned from Progress and Achievements Made during Regional and Global Measles Resurgences.

Vaccines
2024

Congenital Rubella Syndrome Does Not Increase with Introduction of Rubella-Containing Vaccine.

Vaccines
2024

Successful Elimination of Endemic Rubella in the WHO European Region. Is It Proper to Remove the Recommendation for Preconceptional Immunization?

International journal of environmental research and public health
2024

Secondary Glaucoma after Cataract Surgery Performed in Infancy in Congenital Rubella Syndrome: A Case Control Study.

Ophthalmology. Glaucoma
2024

Selection of DNA aptamer for label-free electrochemical aptasensor for the detection of rubella virus.

Talanta
2024

Rubella immunity among pregnant women and the burden of congenital rubella syndrome (CRS) in India, 2022.

Vaccine
2024

Accelerating Global Measles and Rubella Eradication-Saving Millions of Lives, Preventing Disability, and Averting the Next Pandemic.

Vaccines
2024

Sustaining the Elimination of Measles, Rubella and Congenital Rubella Syndrome in the Americas, 2019-2023: From Challenges to Opportunities.

Vaccines
2024

Comparison of Congenital Rubella Syndrome Cases at a Philippine Tertiary Hospital from 2009-2012 to 2019-2022.

Acta medica Philippina
2024

The impact of sub-national heterogeneities in demography and epidemiology on the introduction of rubella vaccination programs in Nigeria.

Vaccine
2024

Rubella in Poland in 2021.

Przeglad epidemiologiczny
2024

Anti-rubella seroprevalence assessment in an adult sample population in Italy.

Annali di igiene : medicina preventiva e di comunita
2024

Development of a real-time fluorescent reverse transcription loop-mediated isothermal amplification assay with quenching primers for rapid detection of rubella virus.

Journal of virological methods
2024

Age-specific prevalence of IgG against measles/rubella and the impact of routine and supplementary immunization activities: A multistage random cluster sampling study with mathematical modelling.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2024

Identifying the population susceptible to rubella in Japan, 2020: Fine-scale risk mapping.

Journal of infection and public health
2024

A case of congenital rubella syndrome and epidemiology of related cases in China, 2014-2023.

Human vaccines &amp; immunotherapeutics
2024

Progress Toward Rubella and Congenital Rubella Syndrome Elimination - Worldwide, 2012-2022.

MMWR. Morbidity and mortality weekly report
2023

Seroprevalence and risk factors for rubella infection in pregnant women attending a tertiary hospital in Kano-Nigeria.

The Pan African medical journal
2024

A single-point mutation in the rubella virus E1 glycoprotein promotes rescue of recombinant vesicular stomatitis virus.

mBio
2024

Priorities for hearing loss prevention and estimates of global cause-specific burdens of hearing loss: a systematic rapid review.

The Lancet. Global health
2024

Evaluating the potential impact of rubella-containing vaccine introduction on congenital rubella syndrome in Afghanistan, Dem. Republic of Congo, Ethiopia, Nigeria, and Pakistan: A mathematical modeling study.

PLOS global public health
2024

Congenital cytomegalovirus infection in newborns suspected of congenital rubella syndrome in Iran: a cross-sectional study.

BMC pediatrics
2023

A phase II/III randomised, comparative study evaluating the safety and immunogenicity of Biological E's live, attenuated Measles-Rubella vaccine in 9-12 month old healthy infants.

Contemporary clinical trials communications
2023

Rubella Vaccine Uptake among Women of Childbearing Age in Healthcare Settings.

Healthcare (Basel, Switzerland)
2023

A Study Prevalence of Congenital Rubella Syndrome Cases Before and After Rubella Vaccination Campaign.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
2023

Effect evaluation of rubella knowledge attitudes and practices (KAP) intervention on parents of 0 to 2 year old children in Chongqing, China.

Medicine
2024

Facial dysmorphism in congenital rubella syndrome.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2024

Fundus imaging features of congenital rubella retinopathy.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2023

Anesthetic considerations in an adult congenital rubella syndrome-patent ductus arteriosus ligation in a resource-limited setting.

Annals of cardiac anaesthesia
2023

Decreases in Congenital Rubella Syndrome Reflect Concerted Efforts Toward Rubella and Measles Elimination.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2023

Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2022.

Communicable diseases intelligence (2018)
2023

Efficacy of Rubella Vaccination after Co-Inoculation with Rhogam.

Viruses
2023

Rubella virus genotype 2B endemicity and related utility of serum-based molecular characterization in Uganda.

BMC research notes
2023

Estimates of the global burden of Congenital Rubella Syndrome, 1996-2019.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2023

Nucleoside analogs NM107 and AT-527 are antiviral against rubella virus.

PNAS nexus
2023

Profile of cardiac lesions among laboratory confirmed congenital rubella syndrome (CRS) infants: a nationwide sentinel surveillance, India, 2016-22.

The Lancet regional health. Southeast Asia
2023

Changes in the Epidemiology of Rubella: The Influence of Vaccine-Introducing Methods and COVID-19.

Vaccines
2023

Congenital Rubella Syndrome Following Rubella Vaccination During Pregnancy.

Pediatrics
2023

Bilateral Congenital Stromal Corneal Cysts: Report of a Unique Case.

Cureus
2023

Simultaneous seroprevalence of Toxoplasma gondii and rubella virus infections in pregnant women in Dakar (Senegal).

Tropical parasitology
2023

Lens Coloboma: A Rare Association of Congenital Rubella Syndrome.

Cureus
2023

Progress Toward Rubella Elimination - World Health Organization South-East Asia Region, 2013-2021.

MMWR. Morbidity and mortality weekly report
2023

Rubella seroprevalence among pregnant women in the region of Rabat, Morocco: a cross-sectional study.

BMJ open
2024

Co-Occurrence of Sensorineural Hearing Loss and Congenital Heart Disease: Etiologies and Management.

The Laryngoscope
2023

Congenital rubella syndrome surveillance in India, 2016-21: Analysis of five years surveillance data.

Heliyon
2023

Seroprevalence of rubella virus infection among antenatal care clients of Halaba Town public health facilities, southern Ethiopia.

Scientific reports
2023

Considerable doubt about rubella screening and vaccination among unvaccinated orthodox protestant women: a mixed-methods study.

BMC public health
2023

Rubella virus infection in endothelial cells reduces angiogenesis via interferon beta-induced CXCL10.

iScience
2023

Comparison of population-based measles-rubella immunoglobulin G antibody prevalence between 2014 and 2019 in Lao People's Democratic Republic: Impacts of the national immunization program.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
2022

ICTV Virus Taxonomy Profile: Matonaviridae 2022.

The Journal of general virology
2022

A Rare Presentation of Polygenic Inheritance Manifesting As Congenital Rubella Syndrome: A Case Report.

Cureus
2023

Cataract surgery outcomes in pediatric patients with systemic comorbidities.

Indian journal of ophthalmology
2022

Rubella virus IgM and IgG antibodies with avidity in pregnant women and outcomes at a tertiary facility in Ghana.

PloS one
2022

Foveal Hypoplasia Related to Congenital Rubella.

Cureus
2022

Progress Toward Measles and Rubella Elimination - India, 2005-2021.

MMWR. Morbidity and mortality weekly report
2022

Phylogenetic analysis of congenital rubella virus from Indonesia: a case report.

BMC pediatrics
2022

Modeling the dynamics of rubella disease with vertical transmission.

Heliyon
2022

Seroprevalence of IgG Rubella among Infants with Features Suggestive of Congenital Rubella Syndrome at a Tertiary Hospital in North Western Tanzania.

The East African health research journal
2022

Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.

MMWR. Morbidity and mortality weekly report
2022

Membrane Sphingomyelin in Host Cells Is Essential for Nucleocapsid Penetration into the Cytoplasm after Hemifusion during Rubella Virus Entry.

mBio
2023

Congenital Rubella syndrome: A short report and literature review.

Tropical doctor
2022

Epidemiology, etiology and clinical associations of congenital heart disease identified during congenital rubella syndrome surveillance.

Journal of tropical pediatrics
2022

Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2021.

Communicable diseases intelligence (2018)
2022

Epidemiological investigation and prevention and control strategies of rubella in Anhui province, China, from 2012 to 2021.

Frontiers in public health
2022

Molecular surveillance of rubella virus in Beijing, China during 2010-2021: Progress and challenges in rubella elimination.

Vaccine
2022

Transcatheter management of combined patent ductus arteriosus and left pulmonary artery stenosis in congenital rubella syndrome: A series of three patients and an insight into case selection for intervention.

Annals of pediatric cardiology
2022

The epidemiology and disease burden of congenital TORCH infections among hospitalized children in China: A national cross-sectional study.

PLoS neglected tropical diseases
2022

Rubella Virus Triggers Type I Interferon Antiviral Response in Cultured Human Neural Cells: Involvement in the Control of Viral Gene Expression and Infectious Progeny Production.

International journal of molecular sciences
2023

A Biotechnological Review on Patents Applied to Rubella Diagnosis.

Recent patents on biotechnology
2022

Progress Toward Measles Elimination - South-East Asia Region, 2003-2020.

MMWR. Morbidity and mortality weekly report
2022

Reduction in Rubella Virus Active Cases among Children and Adolescents after Rubella Vaccine Implementation in Tanzania: A Call for Sustained High Vaccination Coverage.

Vaccines
2022

Enhancement of Rubella Virus Infection in Immortalized Human First-Trimester Trophoblasts Under Low-Glucose Stress Conditions.

Frontiers in microbiology
2022

Retinopathy in Presumed Congenital Rubella Syndrome.

JAMA ophthalmology
2022

Congenital Rubella Syndrome as a possible cause for persistent thrombocytopenia in early infancy: The Forgotten Culprit.

Autopsy &amp; case reports
2022

Low Susceptibility of Rubella Virus in First-Trimester Trophoblast Cell Lines.

Viruses
2022

Leveraging a national biorepository in Zambia to assess measles and rubella immunity gaps across age and space.

Scientific reports
2022

Epidemiology of Congenital Rubella Syndrome Related to the 2012-2013 Rubella Epidemic in Japan.

Journal of the Pediatric Infectious Diseases Society
2022

Factors Predicting Rubella Vaccination and Antibody in Pregnant Women in Japan: A Report from Pregnant Women Health Initiative.

Vaccines
2022

A retrospective 5-year review of rubella in South Africa prior to the introduction of a rubella-containing vaccine.

PloS one
2021

[Seroprevalence in Niger from 2005 to 2019: estimates from the epidemiological surveillance of measles].

Sante publique (Vandoeuvre-les-Nancy, France)
2022

A study of adult rubella outbreak and its implications on increasing number of women in uniform.

Medical journal, Armed Forces India
2022

Susceptibility to Rubella Infection and Incidence of Congenital Rubella Infection: 6 Years Retrospective Study.

International journal of general medicine
2022

Epidemiological analysis of rubella-confirmed cases from measles suspected cases in Ethiopia: Threat for Congenital Rubella Syndrome.

Epidemiology and infection
2022

Progress Toward Rubella and Congenital Rubella Syndrome Control and Elimination - Worldwide, 2012-2020.

MMWR. Morbidity and mortality weekly report
2022

The Burden of Likely Rubella Infection among Healthy Pregnant Women in Abakaliki, Ebonyi State, Nigeria.

Interdisciplinary perspectives on infectious diseases
2022

Rubella in Poland in 2020.

Przeglad epidemiologiczny
2021

An Epidemiological Retrospective and Predictive Analysis of Rubella in Beijing, Haidian District of China.

Journal of tropical pediatrics
2022

Lessons from Ten Years' the Prevalence of Congenital Rubella Syndrome (CRS) in the Young Population Living in a Developing Country, Tehran; Iran.

Infectious disorders drug targets
2022

Newborn Glaucoma: A Neglected Manifestation of Congenital Rubella Syndrome.

Ophthalmology. Glaucoma
2021

Re-verifying the elimination of measles, rubella and congenital rubella syndrome in Canada, 2016-2020.

Canada communicable disease report = Releve des maladies transmissibles au Canada
2021

Examination of scenarios introducing rubella vaccine in the Democratic Republic of the Congo.

Vaccine: X
2022

Detection of Rubella Virus by Tri-Primer RT-PCR Assay and Genotyping by Fragment RT-PCR.

Methods in molecular biology (Clifton, N.J.)
2021

Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2020.

Communicable diseases intelligence (2018)
2022

Evaluation of Diagnostic Accuracy of Eight Commercial Assays for the Detection of Rubella Virus-Specific IgM Antibodies.

Journal of clinical microbiology
2021

Congenital Rubella Syndrome Surveillance After Measles Rubella Vaccination Introduction in Yogyakarta, Indonesia.

The Pediatric infectious disease journal
2021

Rubella Eradication: Not Yet Accomplished, but Entirely Feasible.

The Journal of infectious diseases
2021

Rubella Serosurvey Among Future Healthcare Workers.

Frontiers in public health
2021

Seroprevalence of Measles-, Mumps-, and Rubella-specific antibodies in the German adult population - cross-sectional analysis of the German Health Interview and Examination Survey for Adults (DEGS1).

The Lancet regional health. Europe
2021

High seroprevalence of rubella in Thai children with a 2-dose MMR national immunization policy.

Vaccine
2021

An 11-year trend of rubella incidence cases reported in the measles case-based surveillance system, Ghana.

The Pan African medical journal
2022

Rational Design and Evaluation of the Recombinant Multiepitope Protein for Serodiagnosis of Rubella.

Current pharmaceutical biotechnology
2022

Parenchymal calcification is associated with the neurological prognosis in patients with congenital rubella syndrome.

Congenital anomalies
2021

Factors associated with adults' actions to confirm their own rubella immune status in Japan's drive toward rubella elimination: Cross-sectional online survey of non-healthcare workers in their 20s to 40s.

Environmental health and preventive medicine
2021

Expect the Unexpected-First Case of Congenital Rubella Syndrome in Israel in 20 Years: A Case Report.

Journal of the Pediatric Infectious Diseases Society
2021

Burden of congenital rubella syndrome (CRS) in India based on data from cross-sectional serosurveys, 2017 and 2019-20.

PLoS neglected tropical diseases
2021

A Review on Rubella Vaccine: Iran (1975-2010).

Archives of Razi Institute
2021

Assessment of knowledge and awareness regarding rubella infection among medical professionals seen in IGIMS, Bihar.

Journal of family medicine and primary care
2021

Burden of Rubella virus infection among females attending tertiary care hospitals of Odisha, India: a need for adult women vaccination.

Human vaccines &amp; immunotherapeutics
2021

Progress Toward Rubella Elimination - World Health Organization European Region, 2005-2019.

MMWR. Morbidity and mortality weekly report
2021

Rubella seroprevalence among mothers and incidence of congenital rubella three years after rubella vaccine introduction in Vietnam.

Human vaccines &amp; immunotherapeutics
2021

Congenital Rubella: A Salient Cause of Congenital Heart Defects in Infants.

Journal of tropical pediatrics
2021

Model Comparisons of the Cost Effectiveness of Rubella Vaccination Method in Japanese Adults.

Vaccines
2021

Persistence of Anti-Rubella Immunoglobulin G Antibody Titers in Young Adults Involved in a Short-Term Periodic Immunization in Japan.

Japanese journal of infectious diseases
2021

Molecular and Structural Insights into the Life Cycle of Rubella Virus.

Journal of virology
2021

A comparative genomics-based study of positive strand RNA viruses emphasizing on SARS-CoV-2 utilizing dinucleotide signature, codon usage and codon context analyses.

Gene reports
2021

Is 20/20 visual outcome a reality in rubella cataract? - Prognostic factors in children with cataract associated with congenital rubella syndrome.

Indian journal of ophthalmology
2020

Rubella in Poland in 2018.

Przeglad epidemiologiczny
2021

Assessing the burden of congenital rubella syndrome in China and evaluating mitigation strategies: a metapopulation modelling study.

The Lancet. Infectious diseases
2021

The Impact of Rubella Vaccine Introduction on Rubella Infection and Congenital Rubella Syndrome: A Systematic Review of Mathematical Modelling Studies.

Vaccines
2021

The Capsid Protein of Rubella Virus Antagonizes RNA Interference in Mammalian Cells.

Viruses
2021

Immunogenicity, duration of protection, effectiveness and safety of rubella containing vaccines: A systematic literature review and meta-analysis.

Vaccine
2020

Newborn with bilateral congenital cataracts: Never forget congenital rubella syndrome.

Paediatrics &amp; child health
2021

Rubella in Poland in 2019.

Przeglad epidemiologiczny
2020

Novel facial characteristics in congenital rubella syndrome: a study of 115 cases in a cardiac hospital of Bangladesh.

BMJ paediatrics open
2022

Clinical profile and outcome of early surgery in neonatal-onset glaucoma presenting over a 5-year period.

The British journal of ophthalmology
2021

Epidemiological Characteristics, Seasonal Dynamic Patterns, and Associations with Meteorological Factors of Rubella in Shaanxi Province, China, 2005-2018.

The American journal of tropical medicine and hygiene
2020

Pattern of congenital heart disease among children presenting to the Uganda Heart Institute, Mulago Hospital: a 7-year review.

African health sciences
2020

Rubella Immunity among Italian Female Healthcare Workers: A Serological Study.

International journal of environmental research and public health
2020

Ophthalmic Abnormalities among Children Treated with Cochlear Implants.

The journal of international advanced otology
2021

Prediction of probability of rubella based on eye outcomes (PORBEO Nomogram)-a cross-sectional sentinel surveillance of 1134 infants.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2021

Differences in levels of rubella hemagglutination inhibition antibody titers according to birth cohort.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
2020

The epidemiology of rubella, 2007-18: an ecological analysis of surveillance data.

The Lancet. Global health
2020

Rubella Seroprevalence Boost in the Pediatric and Adolescent Population of Florence (Italy) as a Preventive Strategy for Congenital Rubella Syndrome (CRS).

Vaccines
2020

Relatives of rubella virus in diverse mammals.

Nature
2020

Rubella outbreak among workers in three small- and medium-size business establishments associated with imported genotype 1E rubella virus-Shizuoka, Japan, 2015.

Vaccine
2020

[Possibilities to diagnose hearing impairment in children].

Lakartidningen
2020

Laboratory confirmation of congenital rubella syndrome in South Korea in 2017: A genomic epidemiological investigation.

Vaccine
2020

Congenital Rubella Syndrome profile of audiology outpatient clinic in Surabaya, Indonesia.

Infectious disease reports
2020

Profile of congenital rubella syndrome in Soetomo General Hospital Surabaya, Indonesia.

Infectious disease reports
2020

Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2019.

Communicable diseases intelligence (2018)
2020

Comparing catch-up vaccination programs based on analysis of 2012-13 rubella outbreak in Kawasaki City, Japan.

PloS one
2020

Rubella transmissibility and reproduction number (Ro): A critical appraisal of the prospects for its control in Nigeria.

The Nigerian postgraduate medical journal
2020

Rubella Vaccine Introduction in the South African Public Vaccination Schedule: Mathematical Modelling for Decision Making.

Vaccines
2020

A microneedle patch for measles and rubella vaccination: a game changer for achieving elimination.

Current opinion in virology
2020

[Re-emerging Rubella Epidemic and Public Health Measures in Japan].

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
2021

The status of rubella IgG antibody titer between antenatal and postnatal among pregnant non-immune to rubella.

Human vaccines &amp; immunotherapeutics
2020

Faster waning of the rubella-specific immune response in young pregnant women immunized with MMR at 15 months.

American journal of reproductive immunology (New York, N.Y. : 1989)
2020

Progress Toward Rubella Elimination - Western Pacific Region, 2000-2019.

MMWR. Morbidity and mortality weekly report
2020

Strategies for elimination of rubella in pregnancy and of congenital rubella syndrome in high and upper-middle income countries.

Journal of preventive medicine and hygiene
Ver todos os 535 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de rubéola congênita.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de rubéola congênita

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Rubella outbreak investigation in Adigrat town of Eastern Tigray, Northern Ethiopia, 2024: case-control study design.
    BMC public health· 2026· PMID 41555289mais citado
  2. Clinical progress note: Rubella.
    Journal of hospital medicine· 2026· PMID 40938300mais citado
  3. Notes from the Field: Congenital Rubella Syndrome - Florida, 2025.
    MMWR. Morbidity and mortality weekly report· 2026· PMID 41785150mais citado
  4. Modeling Reemergence of Vaccine-Eliminated Infectious Diseases Under Declining Vaccination in the US.
    JAMA· 2025· PMID 40272967mais citado
  5. A population-representative serosurvey estimating vaccine-induced immunity against measles, rubella, hepatitis B and severe acute respiratory syndrome coronavirus 2 in Timor-Leste.
    The Lancet regional health. Southeast Asia· 2025· PMID 40084157mais citado
  6. Perception of Rubella and readiness to accept the vaccine among medical students in Enugu and Ebonyi States, Nigeria.
    BMC Infect Dis· 2025· PMID 41430157recente
  7. Rubella immunization policy in Japan: Immunity gaps arising from program differences and inconsistent cutoff standards.
    Hum Vaccin Immunother· 2025· PMID 41212141recente
  8. Ocular manifestations of vaccine-preventable diseases: A comprehensive review.
    Vaccine· 2025· PMID 41205407recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:290(Orphanet)
  2. MONDO:0017361(MONDO)
  3. GARD:4744(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Artigo Wikipedia(Wikipedia)
  6. Q1724539(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome de rubéola congênita
Compêndio · Raras BR

Síndrome de rubéola congênita

ORPHA:290 · MONDO:0017361
Prevalência
Unknown
Herança
Not applicable
CID-10
P35.0 · Síndrome da rubéola congênita
CID-11
Início
Antenatal, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C0035921
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades